Cowen Inc. acquired a new stake in Agilent Technologies Inc (NYSE:A) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 17,500 shares of the medical research company’s stock, valued at approximately $1,172,000.
Several other institutional investors have also made changes to their positions in A. Front Row Advisors LLC purchased a new stake in Agilent Technologies during the 4th quarter valued at $106,000. AMG National Trust Bank purchased a new stake in Agilent Technologies during the 4th quarter valued at $201,000. Premia Global Advisors LLC purchased a new stake in Agilent Technologies during the 4th quarter valued at $204,000. Steward Partners Investment Advisory LLC purchased a new stake in Agilent Technologies during the 3rd quarter valued at $213,000. Finally, Cannell Peter B & Co. Inc. purchased a new stake in Agilent Technologies during the 3rd quarter valued at $215,000.
Agilent Technologies Inc (NYSE:A) opened at $69.90 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 3.23 and a quick ratio of 2.78. Agilent Technologies Inc has a 1-year low of $52.26 and a 1-year high of $75.00. The company has a market cap of $22,557.92, a price-to-earnings ratio of 27.96, a price-to-earnings-growth ratio of 2.33 and a beta of 1.30.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 14th. The medical research company reported $0.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.58 by $0.08. Agilent Technologies had a net margin of 4.25% and a return on equity of 17.70%. The business had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.16 billion. During the same period in the prior year, the business earned $0.53 EPS. sell-side analysts predict that Agilent Technologies Inc will post 2.68 earnings per share for the current fiscal year.
Several brokerages have weighed in on A. Robert W. Baird reissued a “buy” rating and set a $76.00 price target on shares of Agilent Technologies in a research report on Thursday, January 18th. JPMorgan Chase & Co. increased their price target on shares of Agilent Technologies from $75.00 to $80.00 and gave the company an “overweight” rating in a research report on Thursday, February 15th. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $80.00 price target for the company in a research report on Tuesday, March 13th. Barclays upped their price objective on shares of Agilent Technologies from $67.00 to $71.00 and gave the stock an “overweight” rating in a report on Tuesday, November 21st. Finally, Deutsche Bank set a $75.00 price objective on shares of Agilent Technologies and gave the stock a “buy” rating in a report on Tuesday, November 21st. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Agilent Technologies currently has an average rating of “Buy” and an average target price of $71.27.
In related news, insider Mark Doak sold 15,567 shares of the stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $68.00, for a total value of $1,058,556.00. Following the completion of the transaction, the insider now directly owns 71,104 shares in the company, valued at approximately $4,835,072. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Michael R. Mcmullen sold 21,850 shares of the stock in a transaction dated Thursday, January 18th. The stock was sold at an average price of $72.50, for a total transaction of $1,584,125.00. Following the completion of the transaction, the chief executive officer now owns 324,687 shares of the company’s stock, valued at $23,539,807.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 116,670 shares of company stock valued at $8,317,523.
ILLEGAL ACTIVITY WARNING: This report was first reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://ledgergazette.com/2018/03/18/cowen-inc-invests-1-17-million-in-agilent-technologies-inc-a.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.